These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 12227881)
1. How progestins influence the cardiovascular effect of hormone replacement therapy. Rosano GM; Mercuro G; Vitale C; Rossini P; Galetta P; Fini M Gynecol Endocrinol; 2001 Dec; 15 Suppl 6():9-17. PubMed ID: 12227881 [TBL] [Abstract][Full Text] [Related]
2. Comparative cardiovascular effects of different progestins in menopause. Rosano GM; Fini M Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197 [TBL] [Abstract][Full Text] [Related]
3. The relative effects of progesterone and progestins in hormone replacement therapy. Rosano GM; Sarais C; Zoncu S; Mercuro G Hum Reprod; 2000 Jun; 15 Suppl 1():60-73. PubMed ID: 10928419 [TBL] [Abstract][Full Text] [Related]
4. Progestin replacement in the menopause: effects on the endometrium and serum lipids. Williams DB; Moley KH Curr Opin Obstet Gynecol; 1994 Jun; 6(3):284-92. PubMed ID: 8038417 [TBL] [Abstract][Full Text] [Related]
5. Postmenopausal women and cardiovascular risk: impact of hormone replacement therapy. Rosano GM; Fini M Cardiol Rev; 2002; 10(1):51-60. PubMed ID: 11790270 [TBL] [Abstract][Full Text] [Related]
6. Cardioprotective effects of ovarian hormones and the HERS in perspective. Rosano GM; Graziottin A; Fini M Maturitas; 2000 Apr; 34 Suppl 2():S3-10. PubMed ID: 10915917 [TBL] [Abstract][Full Text] [Related]
7. Metabolic and vascular effect of progestins in post-menopausal women. Implications for cardioprotection. Rosano GM; Vitale C; Silvestri A; Fini M Maturitas; 2003 Dec; 46 Suppl 1():S17-29. PubMed ID: 14670642 [TBL] [Abstract][Full Text] [Related]
8. A review of the cardiovascular and breast actions of drospirenone in preclinical studies. Simoncini T; Genazzani AR Climacteric; 2010 Feb; 13(1):22-33. PubMed ID: 19938948 [TBL] [Abstract][Full Text] [Related]
9. Effects of progestins in different hormone replacement therapy formulations on estrogen-induced lipid changes in postmenopausal women. Shulman LP Am J Cardiol; 2002 Jun; 89(12A):47E-54E; discussion 54E-55E. PubMed ID: 12084405 [TBL] [Abstract][Full Text] [Related]
10. The menopause: benefits and risks of estrogen-progestogen replacement therapy. Gambrell RD Fertil Steril; 1982 Apr; 37(4):457-74. PubMed ID: 7040116 [TBL] [Abstract][Full Text] [Related]
12. The adverse effects of hormonal therapy. Bush TL Cardiol Clin; 1986 Feb; 4(1):145-52. PubMed ID: 3518931 [TBL] [Abstract][Full Text] [Related]
13. [Role of hormone replacement therapy during menopause in the cardiovascular prevention]. Turpin G Ann Cardiol Angeiol (Paris); 1994 Mar; 43(3):177-80. PubMed ID: 8024230 [TBL] [Abstract][Full Text] [Related]
14. Progestins in the menopause. Sitruk-Ware R J Steroid Biochem Mol Biol; 1999; 69(1-6):185-93. PubMed ID: 10418992 [TBL] [Abstract][Full Text] [Related]
15. Oral contraceptives and coronary heart disease: modulation of glucose tolerance and plasma lipid risk factors by progestins. Crook D; Godsland IF; Wynn V Am J Obstet Gynecol; 1988 Jun; 158(6 Pt 2):1612-20. PubMed ID: 3287933 [TBL] [Abstract][Full Text] [Related]
16. Postmenopausal hormone replacement, risk estimators for coronary artery disease and cardiovascular protection. Mijatovic V; van der Mooren MJ; Stehouwer CD; Netelenbos JC; Kenemans P Gynecol Endocrinol; 1999 Apr; 13(2):130-44. PubMed ID: 10399059 [TBL] [Abstract][Full Text] [Related]
17. A practical guide to prescribing estrogen replacement therapy. Corson SL Int J Fertil Menopausal Stud; 1995; 40(5):229-47. PubMed ID: 8556028 [TBL] [Abstract][Full Text] [Related]
18. The menopause and hormone replacement therapy: lipids, lipoproteins, coagulation and fibrinolytic factors. Tikkanen MJ Maturitas; 1996 Mar; 23(2):209-16. PubMed ID: 8735358 [TBL] [Abstract][Full Text] [Related]